CD4 and neoplasm: We found that cDC2/Treg, CD8+ Teff/Treg, and CD4+ Teff/Treg ratios were significantly increased in tumors from mice treated with 7HP349 compared with vehicle, and these ratios were negatively correlated with tumor burden in mice treated with 7HP349 (Supplemental Figure 11B).